| Ticker Symbol: | SYK |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 2825 Airview Boulevard Kalamazoo MI 49002 269 385-2600 |
| CEO/President: | Stephen P. MacMillan |
| Industry: | Medical Products / Standard Industry Code: 3841 |
| Description: | Stryker Corporation develops, manufactures, and markets specialty surgical and medical products, including orthopaedic implants, bone cement, trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services. |
| Shares Outstanding: | 411,790 (000) | Market Value: | 21,374,250 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 51.79% | Number of Inst.Shareholders: | 30.00% |
| Last Quarter Sales: | 1712.60 ($Mil.) | Last Quarter Net Income: | 305.80 ($Mil.) |
| Last Quarter EPS: | 0.74 | P/E Ratio: | 20 |
| Most Recent Earnings: | 0.73 on 07/17/08 | Earnings Per Share: | 2.64 |
| Most Recent Split: | 2-1 on 05/17/04 | Annual Dividend Rate: | .33 |
| Most Recent Dividend: | 0.330 on 12/27/07 | Annual Dividend Yield: | .64% |


| BOSTON SCIENTIF | -47.50 | 7.31 | |
| MEDTRONIC INC | -32.50 | 40.00 | |
| BAXTER INTL INC | -8.30 | 56.10 | |
| ST. JUDE MEDICA | -30.50 | 32.52 | |
| STRYKER CP | -35.60 | 51.12 |
